Janson Beckett is one of the foremost developers of cosmeceuticals - a class of skincare products that is among the fastest growing in the health and beauty marketplace. Their topical formulations provide a safe and effective program for repairing damaged skin, maintaining the skins improved health, and preventing future skin damage. They specialize in developing high-performance anti-aging treatments that incorporate peptides - scientifically advanced ingredients designed to interrupt the muscle contractions that help cause facial lines. Their first peptide formulation - AlphaDerma CE - was introduced in 2004. Hailed by skin care industry experts as one of the premiere formulations available for restoring skin to its most youthful appearance, AlphaDerma CE has a fiercely loyal customer base and remains the companys flagship product. Fueled by the success of AlphaDerma CE, Janson Beckett today offers a comprehensive portfolio of the finest skin care treatments for both facial and body application.